PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
Status:
Recruiting
Trial end date:
2027-03-01
Target enrollment:
Participant gender:
Summary
The trial is an open, multicenter, explorative, pilot phase II study in a small number of
patients to assess safety and efficacy of stereotactic interstitial photodynamic therapy
(iPDT) with PD L 506 in newly diagnosed supratentorial IDH wild-type glioblastoma.